FIRE-RESISTING GLASS

Details for Australian Patent Application No. 2002351845 (hide)

Owner GUARDIAN FLACHGLAS GMBH BEILICKE, Gert

Inventors BEILICKE, Gert; HELLHAMMER, Gunther; KRILTZ, Uwe

Pub. Number AU-A-2002351845

PCT Number PCT/EP02/12345

PCT Pub. Number WO2003/039857

Priority 101 55 273.4 09.11.01 DE

Filing date 5 November 2002

Wipo publication date 19 May 2003

International Classifications

E06B 003/66 Window sashes, door leaves, or like elements for closing openings - Units comprising two or more parallel glass or like panes in spaced relationship, the panes being permanently secured together, e.g. along the edges

C03C 017/36 Surface treatment of glass, e.g. of devitrified glass, not in the form of fibres or filaments, by coating - at least one coating being a metal

E06B 005/16 Doors, windows, or like closures for special purposes

B32B 017/10 Layered products essentially comprising sheet glass, or fibres of glass, slag or the like

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 101 55 273.4 09.11.01 DE

24 July 2003 Application Open to Public Inspection

  Published as AU-A-2002351845

29 July 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002351846-HIGHLY CONCENTRATED FORMALDEHYDE SOLUTION, PRODUCTION AND REACTION THEREOF

2002351844-Cyclooxygenase-2 inhibitor/histone deacetylase inhibitor combination